These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4194447)

  • 21. [Fluctuations of the long-acting thyroid stimulator (LATS) concentration in the blood and its significance in hyperthyroidism].
    Noguchi A; Kurihara H; Ozeki Y; Sato S
    Nihon Rinsho; 1967 Oct; 25(8):1723-32. PubMed ID: 5626106
    [No Abstract]   [Full Text] [Related]  

  • 22. [Etiology of Basedow's disease, with special reference to LATS].
    Nagata K
    Naika Hokan; 1969 Jul; 16(7):297-317. PubMed ID: 4901097
    [No Abstract]   [Full Text] [Related]  

  • 23. Observations on the nature and significance of the long-acting thyroid stimulator.
    Brown J; Dorrington KJ; Ensor J; Smith BR; Munro DS
    Proc R Soc Med; 1968 Dec; 61(12):1301-2. PubMed ID: 4177972
    [No Abstract]   [Full Text] [Related]  

  • 24. LATS protector, the human thyroid stimulator.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
    [No Abstract]   [Full Text] [Related]  

  • 25. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
    zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
    Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pitfalls in the biological demonstration of the "long acting thyroid stimulator" (LATS)].
    Mertz DP; Stelzer M
    Schweiz Med Wochenschr; 1968 Sep; 98(38):1471-5. PubMed ID: 5680881
    [No Abstract]   [Full Text] [Related]  

  • 29. [Recent advances in studies on LATS].
    Kumahara U; Miyai K; Fukuchi M
    Saishin Igaku; 1967 Jul; 22(7):1373-80. PubMed ID: 4171439
    [No Abstract]   [Full Text] [Related]  

  • 30. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
    Tourneur R; Letonturier P; Sénécal P
    Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
    [No Abstract]   [Full Text] [Related]  

  • 31. [Significance of the "long acting thyroid stimulator"].
    Tourneur R; Letonturier P; Sénécal P
    Cah Med; 1974 Mar; 15(3):121-3. PubMed ID: 4479615
    [No Abstract]   [Full Text] [Related]  

  • 32. [LATS and thyroid antibody level in the blood in Basedow's disease].
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Orv Hetil; 1968 Aug; 109(33):1799-804. PubMed ID: 5714825
    [No Abstract]   [Full Text] [Related]  

  • 33. [The etiopathogenic role of long-acting thyroid stimulator in thyrotoxicosis].
    Papazov G; Milanov S; Platonova E
    Vutr Boles; 1972; 11(2):59-62. PubMed ID: 4679953
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
    Friis T
    Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
    [No Abstract]   [Full Text] [Related]  

  • 35. [Etiology of hyperthyroidism].
    Lemarchand-Béraud T; Vannotti A; Griessen M
    Schweiz Med Wochenschr; 1967 Oct; 97(41):1342-52. PubMed ID: 5631864
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduced sensitivity of the thyroid to thyrotrophic hormone and LATS following treatment with antimicrosomal antibodies.
    Földes J; Takó J; Bános C; Gesztesi E; Juhász J
    Acta Endocrinol (Copenh); 1973 Dec; 74(4):675-84. PubMed ID: 4800904
    [No Abstract]   [Full Text] [Related]  

  • 37. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
    Letonturier P; Tourneur R; Sénécal P
    Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703
    [No Abstract]   [Full Text] [Related]  

  • 38. Evolution of the concept of the pathogenesis of toxic diffuse goitre (Graves' disease) and an assessment of the long-acting thyroid stimulator (L.A.T.S.).
    Hassan HA
    J Egypt Med Assoc; 1978; 61(1-2):111-20. PubMed ID: 583050
    [No Abstract]   [Full Text] [Related]  

  • 39. [TSH and LATS].
    Ochi Y; Hachiya T; Shiomi K; Yoshimura M; Miyazaki T
    Saishin Igaku; 1972 May; 27(5):853-61. PubMed ID: 4339218
    [No Abstract]   [Full Text] [Related]  

  • 40. Failure to produce experimental autoimmune thyrotoxicosis in rabbits immunized with thyroidal microsomes.
    Wall JR; Good BF; Hetzel BS
    Aust J Exp Biol Med Sci; 1973 Oct; 51(5):703-6. PubMed ID: 4787506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.